相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Evaluation of a PET Radioligand to Image O-GlcNAcase in Brain and Periphery of Rhesus Monkey and Knock-Out Mouse
Soumen Paul et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Tau PET imaging: present and future directions
Laure Saint-Aubert et al.
MOLECULAR NEURODEGENERATION (2017)
O-GlcNAcylation and neurodegeneration
Willayat Y. Wani et al.
BRAIN RESEARCH BULLETIN (2017)
Approaches for the discovery of novel positron emission tomography radiotracers for brain imaging
Anne Need et al.
CLINICAL AND TRANSLATIONAL IMAGING (2017)
Roles of tau protein in health and disease
Tong Guo et al.
ACTA NEUROPATHOLOGICA (2017)
Tau imaging in neurodegenerative diseases
M. Dani et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
EARLY CLINICAL RESULTS AND PRECLINICAL VALIDATION OF THE O-GLCNACASE (OGA) INHIBITOR MK-8719 AS A NOVEL THERAPEUTIC FOR THE TREATMENT OF TAUOPATHIES
Sean M. Smith et al.
Alzheimers & Dementia (2016)
Tau: From research to clinical development
David M. Holtzman et al.
ALZHEIMERS & DEMENTIA (2016)
Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging
Victor W. Pike
CURRENT MEDICINAL CHEMISTRY (2016)
A little sugar goes a long way: The cell biology of O-GlcNAc
Michelle R. Bond et al.
JOURNAL OF CELL BIOLOGY (2015)
Efficient 11C-Carbonylation of Isolated Aryl Palladium Complexes for PET: Application to Challenging Radiopharmaceutical Synthesis
Thomas L. Andersen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Tau imaging: early progress and future directions
Victor L. Villemagne et al.
LANCET NEUROLOGY (2015)
[carbonyl-11C]4-Fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([11C]FIMX) is an effective radioligand for PET imaging of metabotropic glutamate receptor 1 (mGluR1) in monkey brain
Jinsoo Hong et al.
NUCLEAR MEDICINE AND BIOLOGY (2015)
O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond
Scott A. Yuzwa et al.
CHEMICAL SOCIETY REVIEWS (2014)
Functional O-GIcNAc modifications: Implications in molecular regulation and pathophysiology
Krithika Vaidyanathan et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Positron Emission Tomography in CNS Drug Discovery and Drug Monitoring
Markus Piel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
O-GIcNAc Modification of tau Directly Inhibits Its Aggregation without Perturbing the Conformational Properties of tau Monomers
Scott A. Yuzwa et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema
Takayuki Inoue et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Palladium-Mediated [11C]Carbonylation at Atmospheric Pressure: A General Method Using Xantphos as Supporting Ligand
Kenneth Dahl et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2013)
O-GlcNAcylation: a new cancer hallmark?
Yann Fardini et al.
FRONTIERS IN ENDOCRINOLOGY (2013)
Exploring Leukocyte O-GlcNAcylation as a Novel Diagnostic Tool for the Earlier Detection of Type 2 Diabetes Mellitus
Clare Springhorn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Development of LC-MS/MS-Based Receptor Occupancy Tracers and Positron Emission Tomography Radioligands for the Nociceptin/Orphanin FQ (NOP) Receptor
Concepcion Pedregal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
On quantitative relationships between drug-like compound lipophilicity and plasma free fraction in monkey and human
Sami S. Zoghbi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
NEURODEGENERATION Recall sugars, forget Alzheimer's
Tony Lefebvre
NATURE CHEMICAL BIOLOGY (2012)
Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation
Scott A. Yuzwa et al.
NATURE CHEMICAL BIOLOGY (2012)
Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure
Ida G. Lunde et al.
PHYSIOLOGICAL GENOMICS (2012)
[carbonyl-11C]Benzyl acetate: Automated radiosynthesis via Pd-mediated [11C]carbon monoxide chemistry and PET measurement of brain uptake in monkey
Shuiyu Lu et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2010)
O-GlcNAc cycling: Implications for neurodegenerative disorders
Brooke D. Lazarus et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Molecular imaging with PET
Simon M. Ametamey et al.
CHEMICAL REVIEWS (2008)
The role of molecular imaging in drug discovery and development
R. J. Hargreaves
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Chemistry with [18F]fluoride ion
Lisheng Cai et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2008)
Radiolabeling of a high potency cannabinoid subtype-1 receptor ligand, N-(4-fluoro-benzyl)-4-(3-(piperidin-1-yl)-indole-1-sulfonyl)benzamide (PipISB), with carbon-11 or fluorine-18
Sean R. Donohue et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2008)
A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo
Scott A. Yuzwa et al.
NATURE CHEMICAL BIOLOGY (2008)
In vivo site-directed radiotracers: a mini-review
Shil Patel et al.
NUCLEAR MEDICINE AND BIOLOGY (2008)
[11C]Carbon monoxide, a versatile and useful precursor in labelling chemistry for PET ligand development
Bengt Langstom et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2007)
Consensus nomenclature for in vivo imaging of reversibly binding radioligands
Robert B. Innis et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
F Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain
N Tzourio-Mazoyer et al.
NEUROIMAGE (2002)